DE69407527T2 - Lagerung von stabilen bicarbonatlösungen - Google Patents
Lagerung von stabilen bicarbonatlösungenInfo
- Publication number
- DE69407527T2 DE69407527T2 DE69407527T DE69407527T DE69407527T2 DE 69407527 T2 DE69407527 T2 DE 69407527T2 DE 69407527 T DE69407527 T DE 69407527T DE 69407527 T DE69407527 T DE 69407527T DE 69407527 T2 DE69407527 T2 DE 69407527T2
- Authority
- DE
- Germany
- Prior art keywords
- container
- bicarbonate
- solution
- acid
- interior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 title claims abstract description 107
- 238000003860 storage Methods 0.000 title claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 146
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 73
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000011343 solid material Substances 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008121 dextrose Substances 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 230000035699 permeability Effects 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 claims description 3
- 229960004106 citric acid Drugs 0.000 claims description 3
- 229940099563 lactobionic acid Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229960005137 succinic acid Drugs 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims 1
- 230000003019 stabilising effect Effects 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 3
- 230000006641 stabilisation Effects 0.000 abstract description 2
- 238000011105 stabilization Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 73
- 238000000502 dialysis Methods 0.000 description 22
- 239000000385 dialysis solution Substances 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 10
- 230000001954 sterilising effect Effects 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 6
- 230000000322 hemodialysis Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 208000010444 Acidosis Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000007950 acidosis Effects 0.000 description 3
- 208000026545 acidosis disease Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002500 ions Chemical group 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- -1 lactate ions Chemical class 0.000 description 2
- 208000006443 lactic acidosis Diseases 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000009988 metabolic benefit Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1666—Apparatus for preparing dialysates by dissolving solids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2024—Separating means having peelable seals
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/052,260 US5383324A (en) | 1993-04-23 | 1993-04-23 | Method for manufacturing and storing stable bicarbonate solutions |
| PCT/US1994/002873 WO1994025084A1 (en) | 1993-04-23 | 1994-03-17 | Method for manufacturing and storing stable bicarbonate solutions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69407527D1 DE69407527D1 (de) | 1998-02-05 |
| DE69407527T2 true DE69407527T2 (de) | 1998-07-16 |
Family
ID=21976430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69407527T Expired - Fee Related DE69407527T2 (de) | 1993-04-23 | 1994-03-17 | Lagerung von stabilen bicarbonatlösungen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5383324A (enExample) |
| EP (1) | EP0647145B1 (enExample) |
| JP (1) | JP3454824B2 (enExample) |
| AT (1) | ATE161426T1 (enExample) |
| AU (1) | AU683878B2 (enExample) |
| CA (1) | CA2138665A1 (enExample) |
| DE (1) | DE69407527T2 (enExample) |
| ES (1) | ES2113645T3 (enExample) |
| GR (1) | GR3025966T3 (enExample) |
| NZ (1) | NZ263691A (enExample) |
| SG (1) | SG48702A1 (enExample) |
| TW (1) | TW266162B (enExample) |
| WO (1) | WO1994025084A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9314621D0 (en) * | 1993-07-14 | 1993-08-25 | Kodak Ltd | Material supply |
| CA2169451C (en) * | 1994-07-01 | 2007-11-13 | Leo Martis | Biochemically balanced peritoneal dialysis solutions |
| US5605934A (en) * | 1995-03-23 | 1997-02-25 | Baxter International Inc. | Method of manufacturing and storing solutions |
| JP2872643B2 (ja) | 1996-05-03 | 1999-03-17 | バクスター・インターナショナル・インコーポレイテッド | 腹膜透析システム、腹膜透析液のパッケージングシステムおよびパッケージ形成方法 |
| CA2258535C (en) * | 1996-06-17 | 2002-05-28 | Otsuka Pharmaceutical Factory, Inc. | Bicarbonate-containing medical solution packaging and ph indicating device |
| US5881879A (en) * | 1997-02-07 | 1999-03-16 | Baxter International Inc. | System for preserving and delivering gas-containing solutions |
| IT1307734B1 (it) * | 1999-01-29 | 2001-11-19 | Bieffe Medital Spa | Cartuccia per dialisi contenente bicarbonato di sodio. |
| CA2362482A1 (en) | 1999-03-03 | 2000-09-08 | Eli Lilly And Company | Processes for making pharmaceutical oral ecb formulations and compositions |
| AU3351299A (en) * | 1999-03-25 | 2000-10-16 | Helmut Dr. Becker | Method and supply bag for providing a medical solution |
| US6309673B1 (en) | 1999-09-10 | 2001-10-30 | Baxter International Inc. | Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy |
| US7122210B2 (en) * | 2002-01-11 | 2006-10-17 | Baxter International Inc. | Bicarbonate-based solutions for dialysis therapies |
| ITMI20020516A1 (it) * | 2002-03-12 | 2003-09-12 | Gambro Lundia Ab | Liquidi per dialisi peritoneale emodialisi e reintegrazione |
| US7445801B2 (en) * | 2002-06-07 | 2008-11-04 | Baxter International Inc. | Stable bicarbonate-based solution in a single container |
| US6991800B2 (en) | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
| TWI319984B (en) * | 2003-06-06 | 2010-02-01 | Sterile combined preparation | |
| CA2544575C (en) * | 2003-11-10 | 2012-07-10 | Michael Edward Wood | Method and device for pressurizing containers |
| US7935070B2 (en) * | 2005-01-28 | 2011-05-03 | Fresenius Medical Care North America | Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product |
| US7857977B2 (en) * | 2005-07-12 | 2010-12-28 | Rockwell Medical Technologies, Inc. | Packaging of ferric pyrophosphate for dialysis |
| US20110005958A1 (en) * | 2009-07-09 | 2011-01-13 | Onpharma, Inc. | METHODS AND SYSTEMS FOR ADJUSTING THE pH OF MEDICAL BUFFERING SOLUTIONS |
| US8162917B2 (en) * | 2008-05-21 | 2012-04-24 | Onpharma, Inc. | Methods and apparatus for buffering anesthetics |
| US8303566B2 (en) * | 2009-07-09 | 2012-11-06 | Onpharma, Inc. | Methods and apparatus for buffering parenteral solutions |
| US8585963B2 (en) | 2009-07-09 | 2013-11-19 | Onpharma, Inc. | Methods and devices for sterilizing and holding buffering solution cartridges |
| CN102574085B (zh) | 2009-07-09 | 2015-04-15 | 昂法玛公司 | 用于灭菌和容纳缓冲溶液药筒的方法和装置 |
| US9051098B2 (en) * | 2009-10-19 | 2015-06-09 | Inoflate, Llc | Method for pressurizing containers with nitrogen |
| US9056446B2 (en) | 2010-06-30 | 2015-06-16 | Paper-Pak Industries | Absorbent food pad |
| US9585810B2 (en) | 2010-10-14 | 2017-03-07 | Fresenius Medical Care Holdings, Inc. | Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser |
| US9492351B2 (en) | 2010-11-15 | 2016-11-15 | Onpharma, Inc. | Apparatus and methods for sequestering fluids exhausted during fluid transfer |
| US9757401B2 (en) | 2011-11-11 | 2017-09-12 | Nova Neura, Llc | Method for relieving neurogenic pain |
| US10478381B2 (en) | 2014-07-08 | 2019-11-19 | Fenwal, Inc. | Minimization of air ingress in solution containers |
| GR1009075B (el) * | 2016-04-20 | 2017-07-07 | Βερμα Ντραγκς - Verma Drugs Abee | Σακος διττανθρακικου νατριου με ανυδρο κιτρικο οξυ ως σταθεροποιητη του ρη |
| GR1009074B (el) * | 2016-04-20 | 2017-07-07 | Βερμα Ντραγκς - Verma Drugs Abee | Φυσιγγα διττανθρακικου νατριου με ανυδρο κιτρικο οξυ ως σταθεροποιητη του ρη |
| US10882295B2 (en) | 2018-03-09 | 2021-01-05 | Novipax Llc | Absorbent fluff and tissue laminate pads for food packaging |
| US11925703B1 (en) | 2022-07-29 | 2024-03-12 | Xellia Pharmaceuticals Aps | Liquid composition comprising glucose |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3878664A (en) * | 1972-11-27 | 1975-04-22 | Cybersol | Process for producing a therapeutic composition |
| FR2468400A1 (fr) * | 1979-11-01 | 1981-05-08 | Baxter Travenol Lab | Procede et dispositif pour le melange de solutions hypernutritives |
| CA1166966A (en) * | 1980-05-09 | 1984-05-08 | Albert L. Babb | System for bicarbonate dialysate |
| US4489535A (en) * | 1980-10-02 | 1984-12-25 | Veltman Preston Leonard | Materials and method for preparing dialysis solutions containing bicarbonate ions |
| US4397392A (en) * | 1981-01-08 | 1983-08-09 | Intensive Technology, Inc. | Contained blood gas control |
| US4465488A (en) * | 1981-03-23 | 1984-08-14 | Baxter Travenol Laboratories, Inc. | Collapsible multi-chamber medical fluid container |
| US4396383A (en) * | 1981-11-09 | 1983-08-02 | Baxter Travenol Laboratories, Inc. | Multiple chamber solution container including positive test for homogenous mixture |
| US4584176A (en) * | 1984-03-19 | 1986-04-22 | Oliver James C | Method and apparatus for storing bicarbonate dialysate |
| IT1214872B (it) * | 1984-04-06 | 1990-01-18 | Mariano Feriani | Sacca contenente due o piu'sostanze per infusione ad uso medicale, poste in scomparti separati, comprendente mezzi atti a consentire la miscelazione di tali sostanze solo al momento dell'uso. |
| EP0209607B1 (en) * | 1985-05-31 | 1989-12-20 | Hans Dr. Dietl | Hemodialysis liquid feed system |
| GR870129B (en) * | 1987-01-27 | 1987-02-04 | Giatzidis Ippokratis | Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis |
| US4784495A (en) * | 1987-02-06 | 1988-11-15 | Gambro Ab | System for preparing a fluid intended for a medical procedure by mixing at least one concentrate in powder form with water |
| US5092838A (en) * | 1989-11-30 | 1992-03-03 | Baxter International Inc. | Histidine buffered peritoneal dialysis solution |
| AU627309B2 (en) * | 1989-05-26 | 1992-08-20 | Terumo Kabushiki Kaisha | Preparation for blood dialysis and method for production thereof |
| DE3917251A1 (de) * | 1989-05-26 | 1990-11-29 | Fresenius Ag | Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit |
| US5071558A (en) * | 1989-08-11 | 1991-12-10 | Nikkiso Co., Ltd. | Sodium bicarbonate dialysate |
| DK0437274T3 (da) * | 1990-01-12 | 1994-10-10 | Bartz Volker | Bicarbonat- og calciumholdig infusions- og dialyseopløsning |
| SE505967C2 (sv) * | 1990-10-15 | 1997-10-27 | Gambro Ab | Förfarande respektive anläggning för beredning av en medicinsk lösning, t ex en dialyslösning |
-
1993
- 1993-04-23 US US08/052,260 patent/US5383324A/en not_active Expired - Fee Related
-
1994
- 1994-03-16 TW TW83102278A patent/TW266162B/zh active
- 1994-03-17 AU AU64473/94A patent/AU683878B2/en not_active Ceased
- 1994-03-17 EP EP94912244A patent/EP0647145B1/en not_active Expired - Lifetime
- 1994-03-17 WO PCT/US1994/002873 patent/WO1994025084A1/en not_active Ceased
- 1994-03-17 CA CA 2138665 patent/CA2138665A1/en not_active Abandoned
- 1994-03-17 SG SG1995002031A patent/SG48702A1/en unknown
- 1994-03-17 NZ NZ263691A patent/NZ263691A/en unknown
- 1994-03-17 JP JP52424994A patent/JP3454824B2/ja not_active Expired - Fee Related
- 1994-03-17 AT AT94912244T patent/ATE161426T1/de not_active IP Right Cessation
- 1994-03-17 DE DE69407527T patent/DE69407527T2/de not_active Expired - Fee Related
- 1994-03-17 ES ES94912244T patent/ES2113645T3/es not_active Expired - Lifetime
-
1998
- 1998-01-21 GR GR980400136T patent/GR3025966T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6447394A (en) | 1994-11-21 |
| ES2113645T3 (es) | 1998-05-01 |
| DE69407527D1 (de) | 1998-02-05 |
| EP0647145A1 (en) | 1995-04-12 |
| WO1994025084A1 (en) | 1994-11-10 |
| AU683878B2 (en) | 1997-11-27 |
| SG48702A1 (en) | 1998-05-18 |
| ATE161426T1 (de) | 1998-01-15 |
| JP3454824B2 (ja) | 2003-10-06 |
| US5383324A (en) | 1995-01-24 |
| GR3025966T3 (en) | 1998-04-30 |
| EP0647145B1 (en) | 1997-12-29 |
| CA2138665A1 (en) | 1994-11-10 |
| TW266162B (enExample) | 1995-12-21 |
| NZ263691A (en) | 1996-11-26 |
| JPH07508678A (ja) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69407527T2 (de) | Lagerung von stabilen bicarbonatlösungen | |
| DE60035016T2 (de) | Aktivsauerstoff enthaltende Lösung zur Förderung von Gewebewachstum an Wundstellen | |
| EP0399549B2 (de) | Zweikammerbeutelsystem zur Herstellung einer für die CAPD einsetzbaren Dialysierflüssigkeit | |
| DE19748290B4 (de) | Lösung für die Peritonealdialyse | |
| EP0161471B1 (de) | Behälter für eine bicarbonathaltige Flüssigkeit | |
| DE69114356T2 (de) | System zur Steuerung einer medizinischen Behandlung, beispielsweise einer Dialyse. | |
| EP1101483B1 (de) | Mehrkammerbehälter, mit Glucosekonzentratkompartiment und Salzsäurekonzentratkompartiment | |
| EP0437274B1 (de) | Bicarbonat und Calcium enthaltende Infusions- und Dialysierlösung | |
| EP1038552B2 (de) | Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung | |
| EP0564672B1 (de) | Wässrige Peritonealdialyse-Lösung | |
| DE69822191T2 (de) | Vorrichtung zum aufbauen einer atmosphäre in einer zone | |
| CH661441A5 (de) | Verfahren zur herstellung einer fuer den entsprechenden krankheitsfall optimierten elektrolytloesung zur anwendung in der haemodialyse. | |
| DE69513637T2 (de) | Zubereitung und Vorrichtung zur Entfernung von überschüssigen Wasserstoffionen in Menschen | |
| DE2358759A1 (de) | Verfahren zur herstellung einer therapeutischen zusammensetzung | |
| DE2825134A1 (de) | Automatisches intermittierendes blutreinigungsverfahren | |
| DE69111620T2 (de) | Vorrichtung zum verbinden von flüssigkeitsleitungen für medizinische zwecke. | |
| DE69501314T2 (de) | Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält | |
| JPH06105905A (ja) | 重炭酸配合液及びその収容容器 | |
| DE10217356B4 (de) | Lösung für die Peritonealdialyse | |
| EP2316460B1 (de) | Lösung für die Peritonealdialyse | |
| JP2000051348A (ja) | 腹膜透析液 | |
| DE8718135U1 (de) | Ein System zur Herstellung einer Flüssigkeit, vorgesehen für eine medizinische Anwendung, durch Mischen von zumindest einem Konzentrat in Form von Pulver mit Wasser, und eine Kartusche für die Anwendung in diesem System |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |